DOMANTIS SUCCESSFUL IN PATENT OPPOSITION PROCEEDINGS

Domantis Limited, the human Domain Antibody Therapeutics company, has successfully opposed European patent number EP0656946, leading to a major amendment of the main claim in the patent and a significant narrowing of the scope of 34 of the 41 other claims. The decision of the Opposition Division of the European Patent Office (EPO) reaffirms Domantis' complete freedom to operate in the field of human Domain Antibodies.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-01-2005/0004098496&EDATE=)